Predicting Survivability of Cancer Patients with Metastatic Patterns Using Explainable AI

The model achieved 82% accuracy (AUC of 0.82) in predicting cancer patient survival, but this means it was wrong roughly 1 in 5 times—highlighting the importance of using AI predictions as a clinical tool alongside, not instead of, expert medical judgment.

The researchers prioritized explainability by using SHAP analysis to identify which factors most influenced survival predictions (metastatic site count, tumor mutation burden, and organ-specific metastases), making the "black box" AI decisions transparent enough for clinicians to understand and trust the recommendations.

The study analyzed 25,775 patients across 27 cancer types, demonstrating that responsible AI development in healthcare requires large, diverse datasets to ensure findings apply broadly rather than to narrow patient populations, reducing bias in predictions.

Multiple validation methods were used—including Kaplan-Meier curves and Cox Proportional Hazards models—to cross-check the AI findings, reflecting responsible research practice by verifying results through established statistical approaches rather than relying solely on machine learning outputs.

The stated goal is "personalized prognosis and treatment planning" rather than replacing clinical decision-making, which reflects an appropriate framing of AI's role in healthcare: augmenting clinician expertise to improve patient outcomes rather than automating critical medical decisions.